Pertussis models to inform vaccine policy

References

• Cherry JD. Pertussis: challenges today and for the future. PLoS Pathog 2013; 9:e1003418; PMID:23935481; http://dx.doi.org/10.1371/journal.ppat.1003418
   PubMed Web of Science ®Google Scholar
• Jackson DW, Rohani P. Perplexities of pertussis: recent global epidemiological trends and their potential causes. Epidemiol Infect 2014; 142:672-84; PMID:23324361; http://dx.doi.org/10.1017/S0950268812003093
   PubMed Web of Science ®Google Scholar
• McIntyre P. Lessons from surveillance: solving the pertussis puzzle. N S W Public Health Bull 2003; 14:69-71; PMID:12806403; http://dx.doi.org/10.1071/NB03022
   PubMedGoogle Scholar
• Wendelboe AM, Van Rie A, Salmaso S, Englund JA. Duration of immunity against pertussis after natural infection or vaccination. Pediatr Infect Dis J 2005; 24(5 Suppl):S58-61; PMID:15876927; http://dx.doi.org/10.1097/01.inf.0000160914.59160.41
   PubMedGoogle Scholar
• Lavine JS, King AA, Bjørnstad ON. Natural immune boosting in pertussis dynamics and the potential for long-term vaccine failure. Proc Natl Acad Sci U S A 2011; 108:7259-64; PMID:21422281; http://dx.doi.org/10.1073/pnas.1014394108
   PubMed Web of Science ®Google Scholar
• Riolo MA, King AA, Rohani P. Can vaccine legacy explain the British pertussis resurgence? Vaccine 2013; 31:5903-8; PMID:24139837; http://dx.doi.org/10.1016/j.vaccine.2013.09.020
   PubMed Web of Science ®Google Scholar
• Rohani P, Drake JM. The decline and resurgence of pertussis in the US. Epidemics 2011; 3:183-8; PMID:22094341; http://dx.doi.org/10.1016/j.epidem.2011.10.001
   PubMed Web of Science ®Google Scholar
• Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006; 367:1926-36; PMID:16765762; http://dx.doi.org/10.1016/S0140-6736(06)68848-X
   PubMed Web of Science ®Google Scholar
• Cherry JD. Pertussis in the preantibiotic and prevaccine era, with emphasis on adult pertussis. Clin Infect Dis 1999; 28 Suppl 2:S107-11; PMID:10447027; http://dx.doi.org/10.1086/515057
   PubMedGoogle Scholar
• Teunis PFM, Van Der Heijden OG, De Melker HE, Schellekens JFP, Versteegh FGA, Kretzschmar MEE. Kinetics of the IgG antibody response to pertussis toxin after infection with B. pertussis. Epidemiol Infect 2002; 129:479-89; PMID:12558330; http://dx.doi.org/10.1017/S0950268802007896
   PubMedGoogle Scholar
• Vynnycky E, White RG. An Introduction to Infectious Disease Modelling. Oxford: Oxford University Press, 2010.
   Google Scholar
• Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. New York: Oxford University Press, 1991.
   Google Scholar
• Wallinga J, Teunis P, Kretzschmar M. Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents. Am J Epidemiol 2006; 164:936-44; PMID:16968863; http://dx.doi.org/10.1093/aje/kwj317
   PubMed Web of Science ®Google Scholar
• Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, Massari M, Salmaso S, Tomba GS, Wallinga J, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med 2008; 5:e74; PMID:18366252; http://dx.doi.org/10.1371/journal.pmed.0050074
   PubMed Web of Science ®Google Scholar
• Rohani P, Zhong X, King AA. Contact network structure explains the changing epidemiology of pertussis. Science 2010; 330:982-5; PMID:21071671; http://dx.doi.org/10.1126/science.1194134
   PubMed Web of Science ®Google Scholar
• Ogunjimi B, Hens N, Goeyvaerts N, Aerts M, Van Damme P, Beutels P. Using empirical social contact data to model person to person infectious disease transmission: an illustration for varicella. Math Biosci 2009; 218:80-7; PMID:19174173; http://dx.doi.org/10.1016/j.mbs.2008.12.009
   PubMed Web of Science ®Google Scholar
• Kretzschmar M, Teunis PFM, Pebody RG. Incidence and reproduction numbers of pertussis: estimates from serological and social contact data in five European countries. PLoS Med 2010; 7:e1000291; PMID:20585374; http://dx.doi.org/10.1371/journal.pmed.1000291
   PubMed Web of Science ®Google Scholar
• de Greeff SC, Dekkers ALM, Teunis P, Rahamat-Langendoen JC, Mooi FR, de Melker HE. Seasonal patterns in time series of pertussis. Epidemiol Infect 2009; 137:1388-95; PMID:19327200; http://dx.doi.org/10.1017/S0950268809002489
   PubMedGoogle Scholar
• Broutin H, Viboud C, Grenfell BT, Miller MA, Rohani P. Impact of vaccination and birth rate on the epidemiology of pertussis: a comparative study in 64 countries. Proc R Soc Lond B Biol Sci 2010; 277:3239-45.
   Google Scholar
• Dafilis MP, Frascoli F, McVernon J, Heffernan JM, McCaw JM. The dynamical consequences of seasonal forcing, immune boosting and demographic change in a model of disease transmission. J Theor Biol 2014; 361:124-32; PMID:25106793; http://dx.doi.org/10.1016/j.jtbi.2014.07.028
   PubMedGoogle Scholar
• Dafilis MP, Frascoli F, Wood JG, Mccaw JM. The influence of increasing life expectancy on the dynamics of SIRS systems with immune boosting. ANZIAM J 2012; 54:50-63; http://dx.doi.org/10.1017/S1446181113000023
   Web of Science ®Google Scholar
• van Boven M, de Melker HE, Schellekens JFP, Kretzschmar M. A model based evaluation of the 1996-7 pertussis epidemic in The Netherlands. Epidemiol Infect 2001; 127:73-85.
   Google Scholar
• Préziosi M-P, Halloran ME. Effects of pertussis vaccination on transmission: vaccine efficacy for infectiousness. Vaccine 2003; 21:1853-61; http://dx.doi.org/10.1016/S0264-410X(03)00007-0
   PubMed Web of Science ®Google Scholar
• Hethcote HW, Horby P, McIntyre P. Using computer simulations to compare pertussis vaccination strategies in Australia. Vaccine 2004; 22:2181-91; PMID:15149775; http://dx.doi.org/10.1016/j.vaccine.2003.11.053
   PubMed Web of Science ®Google Scholar
• Gomes MGM, White LJ, Medley GF. Infection, reinfection, and vaccination under suboptimal immune protection: epidemiological perspectives. J Theor Biol 2004; 228:539-49; PMID:15178201; http://dx.doi.org/10.1016/j.jtbi.2004.02.015
   PubMed Web of Science ®Google Scholar
• Wearing HJ, Rohani P. Estimating the duration of pertussis immunity using epidemiological signatures. PLoS Pathog 2009; 5:e1000647; PMID:19876392; http://dx.doi.org/10.1371/journal.ppat.1000647
   PubMed Web of Science ®Google Scholar
• Hethcote HW. An age-structured model for pertussis transmission. Math Biosci 1997; 145:89-136; PMID:9309930; http://dx.doi.org/10.1016/S0025-5564(97)00014-X
   PubMed Web of Science ®Google Scholar
• Hethcote HW. Simulations of pertussis epidemiology in the United States: effects of adult booster vaccinations. Math Biosci 1999; 158:47-73.
   Google Scholar
• Grenfell BT, Anderson RM. Pertussis in England and Wales: an investigation of transmission dynamics and control by mass vaccination. Proc R Soc Lond B Biol Sci 1989; 236:213-52; PMID:2567004; http://dx.doi.org/10.1098/rspb.1989.0022
   PubMedGoogle Scholar
• Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine 2004; 22:3154-65; PMID:15297068; http://dx.doi.org/10.1016/j.vaccine.2004.01.067
   PubMed Web of Science ®Google Scholar
• Luz PM, Codeço CT, Werneck GL, Struchiner CJ. A modelling analysis of pertussis transmission and vaccination in Rio de Janeiro, Brazil. Epidemiol Infect 2006; 134:850-62; PMID:16316489; http://dx.doi.org/10.1017/S095026880500539X
   PubMed Web of Science ®Google Scholar
• Coudeville L, Van Rie A, Andre P. Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies. Epidemiol Infect 2008; 136:604-20; PMID:17612417; http://dx.doi.org/10.1017/S0950268807009041
   PubMed Web of Science ®Google Scholar
• van Boven M, de Melker HE, Schellekens JFP, Kretzschmar M. Waning immunity and sub-clinical infection in an epidemic model: implications for pertussis in The Netherlands. Math Biosci 2000; 164:161-82; PMID:10748285; http://dx.doi.org/10.1016/S0025-5564(00)00009-2
   PubMed Web of Science ®Google Scholar
• Águas R, Gonçalves G, Gomes MGM. Pertussis: increasing disease as a consequence of reducing transmission. Lancet Infect Dis 2006; 6:112-7; PMID:16439331; http://dx.doi.org/10.1016/S1473-3099(06)70384-X
   PubMed Web of Science ®Google Scholar
• Roberts MG. Can we prevent the next epidemic? The elimination of childhood diseases by mass vaccination. J App Math Decision Sci 2000; 4:175-82; http://dx.doi.org/10.1155/S1173912600000134
   Google Scholar
• Quinn HE, Snelling TL, Macartney KK, McIntyre PB. Duration of protection after first dose of acellular pertussis vaccine in infants. Pediatrics 2014; 133:e513-9; PMID:24515514; http://dx.doi.org/10.1542/peds.2013-3181
   PubMedGoogle Scholar
• McLean AR. Vaccines and their impact on the control of disease. Br Med Bull 1998; 54:545-56; PMID:10326283; http://dx.doi.org/10.1093/oxfordjournals.bmb.a011709
   PubMedGoogle Scholar
• Blackwood JC, Cummings DAT, Broutin H, Iamsirithaworn S, Rohani P. Deciphering the impacts of vaccination and immunity on pertussis epidemiology in Thailand. Proc Natl Acad Sci U S A 2013; 110:9595-600.
   Google Scholar
• Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis 2007; 7:614-24; PMID:17537674; http://dx.doi.org/10.1016/S1473-3099(07)70113-5
   PubMed Web of Science ®Google Scholar
• Hall R. Notifiable diseases surveillance, 1917 to 1991. Communicable Dis Intell 1993; 17:226-36.
   Google Scholar
• Campbell P, McIntyre P, Quinn H, Hueston L, Gilbert GL, McVernon J. Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia. PLoS One 2012; 7:e35874; PMID:22558249; http://dx.doi.org/10.1371/journal.pone.0035874
   PubMed Web of Science ®Google Scholar
• Hethcote HW. Modeling heterogeneous mixing in infectious disease dynamics. In: Isham V, Medley G, eds. Models for Infectious Human Diseases. Press Syndicate of the University of Cambridge, Cambridge, 1996:215-38.
   Google Scholar
• Geard N, McCaw JM, Dorin A, Korb KB, McVernon J. Synthetic population dynamics: a model of household demography. J Artif Soc Social Simul 2013; 16:8.
   Google Scholar
• Rohani P, Earn DJD, Grenfell BT. Impact of immunisation on pertussis transmission in England and Wales. Lancet 2000; 355:285-6; PMID:10675078; http://dx.doi.org/10.1016/S0140-6736(99)04482-7
   PubMed Web of Science ®Google Scholar
• Lavine JS, King AA, Andreasen V, Bjørnstad ON. Immune boosting explains regime-shifts in prevaccine-era pertussis dynamics. PLoS One 2013; 8:e72086
   PubMed Web of Science ®Google Scholar
• Van Buynder PG, Owen D, Vurdien JE, Andrews NJ, Matthews RC, Miller E. Bordetella pertussis surveillance in England and Wales: 1995-7. Epidemiol Infect 1999; 123:403-11; PMID:10694150; http://dx.doi.org/10.1017/S0950268899003052
   PubMed Web of Science ®Google Scholar
• Senzilet LD, Halperin SA, Spika JS, Alagaratnam M, Morris A, Smith B, Sentinel Health Unit Surveillance System Pertussis Working Group. Pertussis is a frequent cause of prolonged cough illness in adults and adolescents. Clin Infect Dis 2001; 32:1691-7; PMID:11360208; http://dx.doi.org/10.1086/320754
   PubMed Web of Science ®Google Scholar
• Tartof SY, Lewis M, Kenyon C, White K, Osborn A, Liko J, Zell E, Martin S, Messonnier NE, Clark TA, et al. Waning immunity to pertussis following 5 doses of DTaP. Pediatrics 2013; 131:e1047-e52; PMID:23478868; http://dx.doi.org/10.1542/peds.2012-1928
   PubMedGoogle Scholar